{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Granisetron Hydrochloride is an injectable prescription medication used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, or surgery. It works by blocking serotonin receptors in the body. Administered intravenously by healthcare professionals, each milliliter contains 1 mg of the active ingredient. Manufactured by Fresenius Kabi USA, LLC. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Granisetron hydrochloride \u2014 ANDA 091136 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091136", "mediaType": "text/html", "title": "Granisetron hydrochloride"}], "identifier": "ANDA091136", "issued": "2016-09-16", "keyword": ["drug-information", "fda", "public-health", "drug-safety", "prescription-drugs"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Granisetron hydrochloride"}